What's in Universidade Federal Fluminense's pipeline?

Universidade Federal Fluminense has 5 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 2 in Phase 1.

Which companies overlap with Universidade Federal Fluminense's portfolio?

Top competitors by shared drug class: All India Institute of Medical Sciences, Cardiochirurgia E.H., Clinica Fabia Mater, GlaxoSmithKline, Hatem AbuHashim.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universidade-federal-fluminense.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Universidade Federal Fluminense — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universidade Federal Fluminense pipeline: 0 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 3 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Anemia · 1
Hematology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

All India Institute of Medical Sciences · 1 shared drug class
Cardiochirurgia E.H. · 1 shared drug class
Clinica Fabia Mater · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hatem AbuHashim · 1 shared drug class
Hospital Universitari Vall d'Hebron Research Institute · 1 shared drug class
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 1 shared drug class
Abdelwahed, Mai Mahmoud Mohamed, M.D. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universidade Federal Fluminense:

Cite this brief

Drug Landscape (2026). Universidade Federal Fluminense — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidade-federal-fluminense. Accessed 2026-05-17.